TOCILIZUMAB
Tracking # 20-941307
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
TOCILIZUMAB IS FDA-INDICATED FOR THE ADULT TREATMENT OF RHEUMATOID ARTHRITIS AND GIANT CELL ARTERITIS AND PEDIATRIC TREATMENT OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. TOCILIZUMAB HAS A NON-FDA-INDICATED USE IN THE TREATMENT OF COVID-19 PNEUMONIA. THIS ACTIVITY HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING PATIENTS PRESCRIBED TOCILIZUMAB FOR RHEUMATOID ARTHRITIS, GIANT CELL ARTERITIS, POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
1h
Practice-Focused Continuing Education
Certified Nurse Practitioner
1h
Practice-Focused Continuing Education
Certified Registered Nurse Anesthetist
1h
Practice-Focused Continuing Education
Clinical Nurse Specialist
1h
Practice-Focused Continuing Education
Licensed Practical Nurse
1h
Practice-Focused Continuing Education
Licensed Psychiatric Technician Nurse
1h
Practice-Focused Continuing Education
Registered Nurse
1h
Practice-Focused Continuing Education
Registered Nurse Practitioner
1h
Practice-Focused Continuing Education
District of Columbia Board of Nursing
Licensed Practical Nurse
1h
Licensed Practical Nurse - Continuing Education
Registered Nurse
1h
Pharmacology Component
Georgia Board of Nursing
Licensed Practical Nurse
1h
General
Registered Professional Nurse
1h
General
South Carolina Board of Nursing
Advanced Practice Registered Nurse
1h
Pharmacotherapeutics
Licensed Practical Nurse
1h
Pharmacotherapeutics
Registered Nurse
1h
Pharmacotherapeutics
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
1h
Relating to professional nursing practice